DK0495008T3 - Vaccinekonjugat til behandling af fuglesygdomme - Google Patents

Vaccinekonjugat til behandling af fuglesygdomme

Info

Publication number
DK0495008T3
DK0495008T3 DK90917281.9T DK90917281T DK0495008T3 DK 0495008 T3 DK0495008 T3 DK 0495008T3 DK 90917281 T DK90917281 T DK 90917281T DK 0495008 T3 DK0495008 T3 DK 0495008T3
Authority
DK
Denmark
Prior art keywords
live virus
treatment
vaccine conjugate
subject
neutralizing
Prior art date
Application number
DK90917281.9T
Other languages
Danish (da)
English (en)
Inventor
Tommy L Fredericksen
Craig E Whitfill
Julius K Tyczkowski
James Paul Thaxton Jr
Original Assignee
Univ Arkansas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Arkansas filed Critical Univ Arkansas
Application granted granted Critical
Publication of DK0495008T3 publication Critical patent/DK0495008T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Chemical Treatment Of Metals (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK90917281.9T 1989-10-02 1990-10-01 Vaccinekonjugat til behandling af fuglesygdomme DK0495008T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41603589A 1989-10-02 1989-10-02
US48067890A 1990-02-15 1990-02-15
US58685990A 1990-09-24 1990-09-24

Publications (1)

Publication Number Publication Date
DK0495008T3 true DK0495008T3 (da) 1997-10-13

Family

ID=27411077

Family Applications (2)

Application Number Title Priority Date Filing Date
DK90917281.9T DK0495008T3 (da) 1989-10-02 1990-10-01 Vaccinekonjugat til behandling af fuglesygdomme
DK96111909T DK0755684T3 (da) 1989-10-02 1990-10-01 Vaccinekonjugat

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK96111909T DK0755684T3 (da) 1989-10-02 1990-10-01 Vaccinekonjugat

Country Status (11)

Country Link
US (4) US5397569A (fr)
EP (2) EP0755684B1 (fr)
AT (2) ATE200735T1 (fr)
AU (2) AU6714290A (fr)
BR (1) BR9007702A (fr)
CA (1) CA2066661C (fr)
DE (2) DE69033728T2 (fr)
DK (2) DK0495008T3 (fr)
ES (2) ES2158200T3 (fr)
IL (1) IL95867A (fr)
WO (1) WO1991004749A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL104382A0 (en) * 1992-01-17 1993-05-13 Solvay Animal Health Inc Vaccine containing acemannan as an adjuvant
JPH07206705A (ja) * 1993-11-03 1995-08-08 American Cyanamid Co 生インオボ（ｉｎ ｏｖｏ）ワクチン
US5807551A (en) * 1996-04-01 1998-09-15 Iowa State University Research Foundation, Inc. Method to provide artificial passive immunity in birds
US6440408B2 (en) 1996-09-30 2002-08-27 University Of Arkansas Method of treatment
US6592869B2 (en) * 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
CA2382652A1 (fr) * 1999-08-24 2001-03-01 Teva Pharmaceutical Industries, Ltd. Composition de vaccin et son procede d'utilisation
US6682754B2 (en) * 1999-11-24 2004-01-27 Willmar Poultry Company, Inc. Ovo delivery of an immunogen containing implant
US20030170823A1 (en) 1999-12-23 2003-09-11 Presnell Scott R. Novel cytokine ZCYTO18
ZA200104596B (en) * 2000-06-09 2001-12-06 Akzo Nobel Nv IBDV strain for in ovo administration.
EP1161953A3 (fr) * 2000-06-09 2004-02-04 Akzo Nobel N.V. Souche d'IBDV pour l'administration in ovo
US7037506B2 (en) 2002-03-08 2006-05-02 Schweltzer Chemical Corporation Ltd. Vaccine accelerator factor (VAF) for improvement of vaccinations in poultry
US7029681B2 (en) 2002-03-08 2006-04-18 Schweitzer Chemical Corporation Multiple and multivalent DNA vaccines in ovo
CA2480163A1 (fr) 2002-03-22 2003-10-09 Zymogenetics, Inc. Anticorps anti-il-tif et leurs methodes d'utilisation dans une inflammation
US6729265B2 (en) * 2002-06-27 2004-05-04 Arkion Life Sciences Llc Supplemented antibody feed to enter the circulating system of newborns
EP1848541A4 (fr) * 2005-02-07 2013-01-16 Pharmalight Inc Procede et dispositif d'administration ophtalmique d'ingredients pharmaceutiquement actifs
WO2008147847A1 (fr) * 2007-05-22 2008-12-04 Baylor College Of Medicine Vaccination à base de complexes immuns en tant que stratégie permettant de renforcer l'immunité des personnes âgées et d'autres populations immunocompromises
WO2013158217A1 (fr) 2012-04-20 2013-10-24 Thomas Jefferson University Anticorps modifié destiné à l'inhibition de fibrose
US10335484B2 (en) 2013-01-08 2019-07-02 Humabs Biomed Sa Methods of generating robust passive and active immune responses
CN103341164B (zh) * 2013-07-19 2015-06-24 天津瑞普生物技术股份有限公司 一种鸡传染性法氏囊病抗原抗体复合物、制剂及制备方法
US11464849B2 (en) 2019-09-11 2022-10-11 Zoetis Services Llc Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2518978A (en) * 1946-09-12 1950-08-15 American Cyanamid Co Hog cholera vaccine
DE1041214B (de) * 1957-03-11 1958-10-16 Dr Med Karl Theurer Verfahren zur Herstellung von Impfstoffen gegen Viruserkrankungen
US3846543A (en) * 1963-01-02 1974-11-05 Monsanto Co Process for the separation of virus from non-viral proteins
US3326767A (en) * 1966-03-21 1967-06-20 Abbott Lab Avian leukosis treatment with inactivated rous sarcoma virus
US3651213A (en) * 1969-05-29 1972-03-21 Monsanto Co Method for the immunization of a living animal body against viral disease
US3853467A (en) * 1973-08-15 1974-12-10 Gen Electric Method and apparatus for immunological detection of biological particles
CA1039649A (fr) * 1973-08-30 1978-10-03 General Electric Company Methode pour former des films d'un complexe immunologique en plusieurs couches
JPS57136528A (en) * 1981-02-09 1982-08-23 Hayashibara Biochem Lab Inc Preparation of viral vaccine
EP0073856A1 (fr) * 1981-08-28 1983-03-16 Gist-Brocades N.V. Vaccins contre la bronchite infectieuse de la volaille, vaccins combinés contre la bronchite infectieuse, procédé de préparation de ces vaccins, procédé de prévention de la bronchite infectieuse et souche de virus de la bronchite infectieuse
US4458630A (en) * 1982-06-22 1984-07-10 The United States Of America As Represented By The Secretary Of Agriculture Disease control in avian species by embryonal vaccination
US4493825A (en) * 1982-10-05 1985-01-15 Iowa State University Research Foundation Purified and antigenically selective vaccines for domestic animals
US4530831A (en) * 1982-11-02 1985-07-23 Akzo N.V. Infectious Bursal Disease vaccine
US4614793A (en) * 1983-10-14 1986-09-30 Merck & Co., Inc. Hepatitis A--subunit antigen
US4743562A (en) * 1984-08-21 1988-05-10 The Board Of Trustees Of The Leland Stanford Junior University Purified human cytomegalovirus protein
US4824668A (en) * 1987-03-09 1989-04-25 Sterwin Laboratories Inc. Attenuated infectious bursal disease virus strain and vaccine therefrom
US4956452A (en) * 1987-06-14 1990-09-11 The University Of Maryland Monoclonal antibody which neutralizes multiple strains of infectious bursal disease virus
US4867975A (en) * 1988-01-27 1989-09-19 University Of Delaware Live attenuated temperature-sensitive avian infectious bronchitis virus vaccines and preparation and use thereof
US5057314A (en) * 1988-09-30 1991-10-15 Whitfill Craig E Low molecular weight antiviral factors

Also Published As

Publication number Publication date
AU6755990A (en) 1991-04-28
CA2066661C (fr) 2001-05-08
ATE150976T1 (de) 1997-04-15
IL95867A (en) 1994-10-07
ES2158200T3 (es) 2001-09-01
DK0755684T3 (da) 2001-08-20
CA2066661A1 (fr) 1991-04-03
AU641958B2 (en) 1993-10-07
IL95867A0 (fr) 1991-07-18
EP0495008A1 (fr) 1992-07-22
US5871748A (en) 1999-02-16
DE69030383T2 (de) 1997-10-23
EP0495008A4 (en) 1993-05-05
EP0755684A1 (fr) 1997-01-29
US5397569A (en) 1995-03-14
US6136319A (en) 2000-10-24
US6299874B1 (en) 2001-10-09
DE69033728T2 (de) 2001-11-22
DE69030383D1 (de) 1997-05-07
WO1991004749A1 (fr) 1991-04-18
EP0495008B1 (fr) 1997-04-02
ES2102368T3 (es) 1997-08-01
EP0755684B1 (fr) 2001-04-25
AU6714290A (en) 1991-04-28
BR9007702A (pt) 1992-08-18
ATE200735T1 (de) 2001-05-15
DE69033728D1 (de) 2001-05-31

Similar Documents

Publication Publication Date Title
DK0495008T3 (da) Vaccinekonjugat til behandling af fuglesygdomme
DE69133516D1 (de) Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen
DK0466037T3 (da) Fremgangsmåde til fremstilling af et gærglucan
CA2116348A1 (fr) Vaccin sirs et methode de diagnostic
BR9713312B1 (pt) preparado de vacina para uso veterinário útil para produzir imunidade ativa contra uma doença bacteriana ou protozoária.
ATE20309T1 (de) Pharmazeutische zubereitung.
ATE429248T1 (de) Verwendung cd28 spezifischer monoklonaler antikörper zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von virusinfektionen
PT98119A (pt) Processo para a preparacao de adjuvantes para vacinas aperfeicoados compreendendo lipopolissacarideos nao toxicos e/ou copolimeros de polioxietileno-polioxipropileno
DE3886999T3 (de) Newcastle-krankheitsvirus-Impfstoff und Methode für seine Verwendung.
DE69333730D1 (de) Impfstoff, der acemannan als adjuvans enthält
ES2056075T3 (es) Anticuerpos monoclonales para regiones especificas antigenicas del virus de inmunodeficiencia humana y procedimientos para su uso.
FR2385401A1 (fr) Vaccin a virus respiratoire syncytial
ATE39055T1 (de) Verfahren zur immunisierung von schweinen gegen die aujeszky-krankheit.
ES2095258T3 (es) Nuevo virus de la enfermedad de la bolsa infecciosa.
Cook et al. Local and systemic antibody class responses to an infectious laryngotracheitis virus vaccine strain
Rosatte Advances in rabies research and control: Applications for the wildlife profession
RU2185853C2 (ru) Способ ревакцинации живой вакциной сейбина на крайнем севере
DK0542895T3 (da) Krydsreaktiv influenza A immunisering
Cicuhini et al. Reisolation of rabies vaccine virus from red foxes orally immunised against rabies and treated with methyl-prednisolone acetate. Reisolamento virus rabido vaccinale da volpi rosse vaccinate per via orale contro la rabbia ed immunosoppresse con acetato di metilprednisolone.
Epstein The Vaccine Control of Virus-Induced Cancers
LV12736A (en) Method for producing concentrated antigen composition against swine erysipelas disease
MY106163A (en) Bcrf1 antagonists for treating epstein-barr virus infections.
RU96123906A (ru) Способ и вакцина для профилактики и лечения иммунодефицитов, например рака
Whitfill et al. Method of treating infectious bursal disease virus infections
RU93052279A (ru) Способ лечения инфекционных заболеваний